Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma.

Shao, Yu-Yun; Chen, Pai-Sheng; Lin, Liang-In; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; Hsu, Chiun; Ou, Da-Liang

Shao, Yu-Yun; Chen, Pai-Sheng; Lin, Liang-In; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; Hsu, Chiun; Ou, Da-Liang.

Afiliação

Shao YY; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan.
Chen PS; Department of Oncology, National Taiwan University Hospital, Taipei City, 10048, Taiwan.
Lin LI; National Taiwan University Cancer Center, Taipei City, 10672, Taiwan.
Lee BS; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan City, 70101, Taiwan.
Ling A; Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei City, 10048, Taiwan.
Cheng AL; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan.
Hsu C; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 10032, USA.
Ou DL; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan.

Br J Cancer ; 126(12): 1806-1814, 2022 06.

Article em En | MEDLINE | ID: mdl-35236936

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; MicroRNAs; Sorafenibe; Apoptose; Carcinoma Hepatocelular/tratamento farmacológico; Carcinoma Hepatocelular/genética; Carcinoma Hepatocelular/metabolismo; Carcinoma Hepatocelular/patologia; Linhagem Celular Tumoral; Proliferação de Células/efeitos dos fármacos; Resistencia a Medicamentos Antineoplásicos; Humanos; Neoplasias Hepáticas/tratamento farmacológico; Neoplasias Hepáticas/genética; Neoplasias Hepáticas/metabolismo; Neoplasias Hepáticas/patologia; MicroRNAs/genética; MicroRNAs/metabolismo; Sorafenibe/farmacologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Sorafenibe / Neoplasias Hepáticas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google